Navigation Links
PharmaPendium(TM) Launches Pharmacokinetics Module
Date:9/14/2010

PharmaPendium(TM) Launches Pharmacokinetics Module -- NEW YORK, September 14, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, New Products & Services Click to view news release full screen  

PharmaPendium(TM) Launches Pharmacokinetics Module

 

NEW YORK, September 14, 2010 /PRNewswire/ --

- Provides Unprecedented Access to Detailed Drug Pharmacokinetics Data and Over 1,000,000 Extracted Exposure Observations From the FDA and EMEA Documents on More Than 2,100 Drugs

Elsevier today announces that it has significantly increased its service offering to pharmaceutical R&D professionals with the launch of a new Pharmacokinetics Module of PharmaPendium(TM), the online resource for authoritative drug development data. The Pharmacokinetics Module allows pharmacokineticists (and related professionals in regulatory affairs, preclinical, safety pharmacology, etc.) to access multiple exposure parameter measurements under various experimental conditions for over 2,100 drugs, enabling the retrieval and analysis of over 1,000,000 pharmacokinetic observations.

"The new Pharmacokinetics Module is not only a faster and more efficient way to search pharmacokinetics data, it is the only place to find this level of comparative exposure information, great for modeling and comparing therapeutic windows earlier in the development process", said Philip MacLaughlin, Senior Product Manager at Elsevier. "This is a level of information that stands alone as a resource for Pharmacokinetics data, as it can save months of work."

With the Pharmacokinetics Module, R&D professionals can model therapeutic windows faster and more accurately than previously possible and discover which preclinical experimental data is predictive of human response, which is not, and why. Users will have the ability to filter comparative data sets for decision support according to a wide variety of fields and special designations, including drug name, species, disease state, food effects, concomitant drugs, route, and exposure parameter.

The PharmaPendium(TM) module is available exclusively to existing PharmaPendium(TM) customers. Purchase options include annual subscription or data purchase (with annual maintenance fee).

About PharmaPendium(TM)

PharmaPendium(TM) (http://www.info.pharmapendium.com/), allows the user to make informed drug development decisions. It is a unique online resource that provides access via a single point to searchable and trusted drug information. It covers close to 4,000 approved drugs, with integrated preclinical, clinical and post-market safety data.

PharmaPendium(TM) is designed to meet the needs of preclinical safety assessment teams, toxicologists, pharmacokineticists, safety pharmacologists, regulatory affairs staff, pharmacoepidemiologists, clinical researchers, drug discovery informatics and information specialists. It enables text-search of FDA Approval Packages and European Medicines Agency (EMEA) European Public Assessment Reports (EPAR) Approval Documents as well as other data sources. Adverse events and toxicity data are carefully extracted from preclinical and clinical studies from all of these sources. Elsevier offers a broad spectrum of solutions to make processes in drug discovery, preclinical and clinical drug development more efficient, e.g. Reaxys (http://www.info.reaxys.com), Embase (http://www.info.embase.com) and PharmaPendium(TM) ( http://www.info.pharmapendium.com). PharmaPendium(TM) is owned and protected by Elsevier Properties SA and used under license.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

About Elsevier Properties SA

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium(TM), Beilstein and Reaxys databases. Trademarks including Reaxys(R), PharmaPendium(TM) and The Lancet(R) are owned and protected by Elsevier Properties SA and used under license. For additional information see http://www.reedelsevier.com.

Media Contact Tom Reller VP, Global Corporate Relations +1-215-239-3508 T.Reller@elsevier.com
'/>"/>

SOURCE Elsevier and Elsevier Properties SA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. EmblemHealth Launches a Comprehensive Health Reform Education Web Site
2. Humidifiers Just Got More Fun for Kids - Vicks Launches Starry Night Cool Moisture Humidifier
3. STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS
4. DSM Launches InnoSyn™ Route Scouting Services to Meet Pharmaceutical Company Needs to Outsource R&D
5. Pharmacy Times Launches iPad Edition
6. Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development
7. NCPA Launches www.PharmacyMatching.com to Connect Independent Pharmacy Buyers and Sellers
8. Millstone Medical Outsourcing Launches New, Improved Company Website
9. Renowned Healthcare Advertising Agency LLNS Re-Launches With Ideas at the Center
10. Invisible Bracelet Launches Nationwide Emergency Medical Notification Text Messaging Service
11. Actemra Post-Launch Success Continues to Gain Momentum with Broader Adoption Compared to Biologic Analog Launches and a Professional Marketing Campaign That Resonates with Rheumatologists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 5, 2016  Syneron Medical Ltd. (NASDAQ: ... announced today that William Griffing , Chief ... scheduled to participate in the Leerink Partners 5 ... 11, 2016 in New York City ... to meet with the Mr. Griffing and will ...
(Date:2/5/2016)... 5, 2016  As people age, it is natural ... recommended screenings and tests that are linked with certain ... for the majority of aging individuals, hearing health is ... the 37.5 million American adults who report some trouble ... make hearing health a 2016 healthy aging priority.[1] ...
(Date:2/5/2016)...  Aralez Pharmaceuticals Inc. ("Aralez") today announced the completion ... Pharmaceuticals Canada Inc. ("Tribute") following approval of the transaction ... combined company will operate under Aralez Pharmaceuticals Inc. ("Aralez"), ... Canada , Ireland ... the terms of the Agreement and Plan of Merger ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... After years as an active staff surgeon ... and cosmetic surgeon Dr. Wayne Carman transitioned to chief of the Division of Plastic ... first three-year term as chief and began a second three-year term in January of ...
(Date:2/5/2016)... ... 2016 , ... Regular gym users know the routine: each January, they see ... the treadmills. It’s a predictable trend. After the excesses of November and December, people ... by joining gyms, starting new walking or running routines, or signing up for Zumba. ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Justin Scott and Dr. Lydia Muccioli of ... Dental Day to individuals in need. The event is scheduled to take place on ... Day is to provide dental care to community members in need. Each patient will ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Health and wellness ... relevant to individuals in the event they are experiencing an illness. Migraines are a ... Americans that are afflicted with migraines would not wish the pain on their worst ...
(Date:2/5/2016)... ... 2016 , ... –This week, Atascadero water heater company First Call Plumbing ... To view the report, click here or see below. , There ... pros and cons, the type chosen is almost entirely up to personal preference. However, ...
Breaking Medicine News(10 mins):